The development of science and technology has allowed more excellent properties of polymer materials to be continuously explored. COP vials are a typical representative of new materials used in the field of pharmaceutical packaging. Thanks to its many excellent properties, the COP bottle is suitable for anti-cancer, anti-tumor, rheumatic, protein and other high value-added drugs.
The COP bottle has high transparency, low birefringence, low water absorption, high rigidity, high heat resistance, low protein adsorption, and good water vapor airtightness. It can be stored in liquid nitrogen and meets FDA standards. According to incomplete statistics, the list of drugs applicable to COP bottles is as follows:
Avastin (bevacizumab), Herceptin (trastuzumab for injection), adalimumab (Humira), palivizumab alias palizolizumab, anthrax (disease) , Combined with chlorambucil, belimumab, treatment of systemic lupus erythematosus, alemtuzumab, certuzumab, trastuzumab, trensuzumab <antineoplastic drugs>, diabetes, rani Buzumab injection, opdivo, pertuzumab, golimumab, panitumumab, primimab, erbitux, infliximab, rituximab ( Rituxan), Etanercept, Bepoetin Alfada, Interferon β-1b, Rituximab <Anti-tumor Drug>, Interferon β-1a, Nurasta, Aflibercept, Gonadotropin Hormones, Anakinra <Interleukin Receptor Blocking Drugs>, Peaspartase Injection.
The above is a list of medicines known in the market that are suitable for COP bottle packaging. With the continuous advancement of technology in the pharmaceutical industry, more new drugs will continue to come out, and the application range of COP bottles will become more common.
没有评论:
发表评论